Targeting energy metabolism in Huntington's disease
暂无分享，去创建一个
[1] M. Mattson,et al. Paroxetine retards disease onset and progression in Huntingtin mutant mice , 2004, Annals of neurology.
[2] L. Raymond,et al. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease , 2004, Molecular and Cellular Neuroscience.
[3] N. Nukina,et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease , 2004, Nature Medicine.
[4] M. Chesselet,et al. The use of transgenic and knock-in mice to study Huntington’s disease , 2003, Cytogenetic and Genome Research.
[5] M. Mattson,et al. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. , 2003, Endocrinology.
[6] M. Mattson,et al. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.